Outcomes after supratherapeutic escitalopram ingestions.

  title={Outcomes after supratherapeutic escitalopram ingestions.},
  author={Frank Lovecchio and Douglas Watts and Joseph Winchell and Jason Knight and Tim McDowell},
  journal={The Journal of emergency medicine},
  volume={30 1},
Escitalopram (ESC) is a new selective serotonin reuptake inhibitor (SSRI) used in the treatment of depression. There are limited data regarding accidental and intentional ESC exposure. We conducted a retrospective chart review of isolated ESC ingestions reported to our regional poison center during 2003-2004. Twenty-eight patients met inclusion criteria. The average patient age was 28.1 years (range 2-75 years) and the average amount of ESC ingested was 62.5 mg (range 5-300 mg from 19 cases… CONTINUE READING